Home › FDA Advisory Panel To Re-Evaluate Diabetes Drug Avandia In June
 

Keywords :   


FDA Advisory Panel To Re-Evaluate Diabetes Drug Avandia In June

2013-04-14 18:20:38| Biotech - Topix.net

Three years after restricting sales of Avandia , the US Food and Drug Administration has scheduled a health advisory panel to re-evaluate the safety of the diabetes drug, various media outlets reported on Friday.

Tags: june panel drug advisory

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.11100 SMAX
15.11ANABoeing 747JA809518cm660g
15.1114
15.11
15.11PS3 CECH2500A
15.11
15.11T
15.11adidas
More »